Adenosine 3',5'-cycfic monophosphate stimulates chloride (Cl-) secretion across airway epithelia. To determine whether cAMP also stimulates HCO3 secretion, we studied cultured canine and human airway epithelial cells bathed in a HCO3-/CO2-buffered, Cl-free solution. Addition of forskolin stimulated an increase in short-circuit current that was likely a result of bicarbonate secretion because it was inhibited by a HCO3-free solution, by addition of the carbonic anhydrase inhibitor, acetazolamide, or by mucosal addition of the anion channel blocker, diphenylamine 2-carboxylate. The current was dependent on Na+ because it was inhibited by removal of Na+ from the submucosal bathing solution, by addition of the Na+ pump inhibitor, ouabain, or by addition of amiloride (1 mM) to the submucosal solution. An increase in cytosolic Ca2" produced by addition of a Ca2+ ionophore also stimulated short-circuit current. These data suggest that cAMP and Ca2" stimulate HCO3 secretion across airway epithelium, and suggest that HCO3 leaves the cell across the apical membrane via conductive pathways. These results may explain previous observations that the short-circuit current across airway epithelia was not entirely accounted for by the sum ofNa+ absorption and Clsecretion. The cAMP-induced secretory response was absent in cystic fibrosis (CF) airway epithelial cells, although Ca2+-stimulated secretion was intact. This result suggests that HCO3 exit at the apical membrane is through the Cl-channel that is defectively regulated in CF epithelia. These results suggest the possibility that a defect in HCO3 secretion may contribute to the pathophysiology of CF pulmonary disease. (J. Clin. Invest.
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Introduction
Olver et al. (1) first reported that airway epithelia absorb sodium (Na+) and secrete chloride (Cl-). They observed that native canine tracheal epithelia bathed in Ringer's solution developed a lumen negative, transepithelial potential difference, suggesting that airway epithelia either absorb cations, secrete submucosa oftracheal epithelia. Their observation that airway epithelia absorb Na' and secrete Cl-has been confirmed by numerous investigators studying nasal, tracheal, and bronchial epithelia from several species (for review see reference 2) .
Since that initial report of transport across airway epithelium, the unidirectional flux of 22Na and 3Cl across native canine tracheal epithelia has been measured under short-circuit conditions by several investigators. Widdicombe et al. (3) , and later Al-Bazzaz and Al-Awqati (4), found that Na' absorption and Cl-secretion accounted for most of the short-circuit current (IC)1 although a small residual ion flux was present. Addition ofdibutyryl cAMP stimulated an increase in both net CQ-secretion and this residual current (5) . When airway epithelia were bathed in Cl--free solution, the net flux of Na' accounted for only 65% of the I, (4) . In addition, when airway epithelia were exposed to furosemide, an inhibitor of basolateral Cl-entry, Na' absorption and Cl-secretion together accounted for only 55% of the I, (6) .
These studies suggest that additional ion species may be transported across the airway. This notion was supported by our observation that cAMP-mediated agonists stimulated an increase in ISC when airway monolayers were bathed in HCO5/ C02-buffered, Cl--free solution, but not when both CQ-and HCO3 were excluded from the bathing solution. Furthermore, this increase in ISC was inhibited by diphenylamine 2-carboxylate (DPC), an anion channel blocker, but not by 10 uM amiloride, a Na+ channel blocker. These findings led us to investigate whether airway epithelia secrete HCO-, which might account for the unexplained residual ion flux noted in previous reports.
Methods
Cell culture. Airway cells were isolated from canine tracheal and human nasal epithelia using enzyme digestion, as previously described (7, 8) . Nasal polyp specimens were obtained, after polypectomy, for upper airway obstruction in patients with allergic rhinitis (control) or cystic fibrosis (CF). Freshly isolated cells were seeded on collagen-coated, semipermeable membranes (Millicell-HA; Millipore, Bedford, MA), and incubated at 37°C in an humidified atmosphere of 5% CO2 in air. Culture media, a mixture of 50% Dulbecco's modified Eagle medium and 50% Ham's F12 medium (DME/F12), was supplemented with 10 gg/ml insulin, 5% fetal calf serum (Sigma Chemical Co., St. Louis, MO), 10 mM nonessential amino acids (Irvine Scientific, Santa Ana, CA), 100 U/ml penicillin, and 100 ,g/ml streptomycin. (Fig. 2) . Second, the increase in L.s was greater in magnitude when forskolin or CPT-cAMP were added in the presence of IBMX, an inhibitor ofcAMP catabolism (shown for CPT-cAMP). Third, isoproterenol and prostaglandin E2, both secretagogues which increase intracellular cAMP concentration, also stimulated LC (shown for isoproterenol). Fourth, responses to each of these agonists were not additive, suggesting a common mechanism of action (shown for CPT-cAMP, forskolin and isoproterenol). These findings support the notion that the actions of these secretagogues are mediated by an increase in intracellular cAMP concentration.
To investigate the ionic basis of the cAMP-stimulated IS, we examined the effect of several agents that inhibit ion transport processes in airway epithelia. Mucosal addition of an anion channel blocker, DPC, inhibited the cAMP-mediated increase in ISC (Fig. 1 ). G, also decreased by 10% after DPC addition. These findings suggested that cAMP may stimulate HCO-secretion via apical anion channels, although DPC might have effects other than anion channel blockade. As an alternative, we considered the possibility that cAMP may stimulate amiloride-insensitive Na+ absorption.
We examined the effect of forskolin in monolayers that were bathed in either Na+-free or HCO--free solutions (solutions 2 and 3, respectively). In each case, the response to forskolin was attenuated (Fig. 3 ), indicating that both Na+ and HCO-were required for the increase in current.
Because HCO--dependence might involve the conversion of CO2 and H20 to H+ and HCO-, we examined the effect of acetazolamide, an inhibitor ofcarbonic anhydrase, on the forskolin-stimulated response. Addition of acetazolamide caused an immediate decrease in IC (Fig. 4) . In contrast, inhibitors of HCO--coupled transport, 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (200 ,uM DIDS), and 4-acetamido-4'-isothiocyanatostilbene 2,2'-disulfonate (250 ,uM SITS), did not attenuate the response to forskolin (n = 4 each).
These results suggested that the forskolin-stimulated current was due to HCO-secretion, and that Na+ might be transepithelial Na' concentration gradient resulted in a current in the direction expected for passive Na' permeability (Fig. 5 ). Subsequent addition of forskolin stimulated an increase in DPC-sensitive current in those monolayers exposed to Na' at the submucosal surface, but not those exposed to Na+ at the mucosal surface. These results indicate that forskolin did not stimulate Na' absorption. Taken together with the HCO3 dependence (Fig. 3) , these results suggest that forskolin stimulates Na+-dependent, HCO secretion.
To further investigate the role of Na' in supporting HCO3 secretion, we examined the effect of Na' transport inhibitors on forskolin-stimulated Isc. When monolayers were preincubated for 20-30 min with ouabain, an inhibitor of Na-K-ATPase activity, the response to forskolin was attenuated (Fig. 6) . Ouabain attenuated this response only when added to the submucosal solution. This suggests that the transmembrane Na' gradient maintained by Na-K-ATPase is required for HCO-3 secretion.
Na+ might be required for HCO- (Fig. 7) . In con- trast, addition of 1 mM amiloride to the mucosal solution had no effect (n = 4). Moreover, addition of a lower concentration (10 ,M) of amiloride to the submucosal solution had no effect. The inhibitory effects of amiloride and ouabain suggest that forskolin induces a recycling of Na' across the basolateral membrane via the Na+/H+ exchanger and Na-K-ATPase. These results suggest that cAMP stimulates HCO-secretion by the following mechanism: Carbonic anhydrase converts CO2 and H20 to H+ and HCO . H+ exits at the basolateral membrane and HCO-exits across the apical membrane (For details, see Discussion). If HCO-exits across the apical membrane through ion channels, the rate of transport should be influenced by the membrane potential. To determine whether membrane depolarization decreases the rate of HCO3 transport, we examined the effect of barium (Ba2+), a potassium (K+) channel blocker known to depolarize airway epithelia (9) . Fig. 8 shows that Ba2+ caused an immediate inhibition of ISC, supporting the notion that HCO-crosses the apical membrane via a conductive pathway.
cAMP-stimulated HCO-secretion was also observed in native airway epithelium mounted in Ussing chambers and bathed in HCO-/CO2-buffered, Cl--free solution (solution 1). Forskolin stimulated an increase in I, (71±28 MA/cm2, n = 3); secretion was blocked by mucosal addition of DPC (Fig. 9 ). 8- Figure 5 . Effect of mu-T TT 1 To further determine the relative contribution ofCl-secretion and HCO-secretion to the cAMP-induced increase in LSS we examined the effects of bumetanide and amiloride (1 mM) that inhibit Ct-(10) and HCO3 (Fig. 7) secretion, respectively. Fig. 11 shows that bumetanide inhibited 81±2% of the forskolin-stimulated Lc when monolayers were bathed in C02-free, NaCl solution (solution 7), and inhibited only 2±2% of the current when monolayers were bathed in HC03/CO2-buffered, Cl--free solution (solution 1). These results indicate that bumetanide inhibits Cl-secretion, but not HCO-secretion. When monolayers are bathed in solution containing both Ct-and HCO-, bumetanide inhibited only 33±7% ofthe Ic; amiloride inhibited the remaining current (Fig. 1 1) .
These results suggest that when epithelia are bathed in solution containing both anions, cAMP stimulates secretion of both Cl-and HCO3-. However, the addition of bumetanide may have shifted current, due predominantly to Cl-secretion to HCO-secretion alone. The following results support this Defective bicarbonate secretion by CF tracheal epithelia. Our results suggest that HCO-secretion occurs via a cAMPstimulated conductive pathway in the apical membrane. Ifthat were the case, we expected that HCO-secretion would be defective in CF airway epithelia. To determine whether cAMP stimulates HCO-secretion across CF nasal airway epithelia, control (atopic) and CF nasal epithelial monolayers were bathed in Cl--free solution (solution 1); addition of forskolin stimulated an increase in ISC in control, but not CF monolayers (Fig. 12) . Although cAMP-mediated Cl-secretion is defective in CF airway epithelia, Ca2'-dependent Cl-secretion is intact (11) . Thus, we examined whether agonists that increase [Ca"+] stimulated HCO-secretion. Bradykinin, ATP, or a calcium ionophore (A23187) were used to stimulate HCO-secretion because these secretagogues increase [Ca2+]c and stimulate Clsecretion across normal and CF airway epithelia (12, 13, 14, 15) . In Clt-free solution, each ofthese secretagogues alone stimulated a transient increase in IC with both normal and CF epithelia (Figs. 12 and 13 ). (17, 18, 19) , our data suggest that HCO-exit occurs through the same cAMP-regulated Cl-channel that is defective in CF. Our results indicate that HCO-secretion by airway epithelia is Na'-dependent (Fig. 3) . The notion that Na' is recycled across the basolateral membrane via Na-K-ATPase and the Na+/H' exchanger is supported by the observations that Na' is required in the submucosal solution only (Fig. 5) , and that secretion is inhibited by submucosal addition of ouabain or 1 mM amiloride (Figs. 6 and 7) . Moreover, inhibition ofNa+/H' exchange by 1 mM amiloride is consistent with acetazolamideinhibited HCO-secretion (Fig. 4) , which should involve a mechanism of H' efflux to maintain intracellular pH.
With the magnitude of HCO-secretion across airway epithelia possibly as great as Cl-secretion (Figs. 9 and 10), one might wonder why HCO-secretion was not apparent in previous studies. The results from two studies suggested at first glance that HCO-secretion was unlikely. First, Al-Bazzaz and Al-Awqati (4) reported that the removal of HCO-from the bath did not diminish cAMP-stimulated I.. Our results are identical ( Fig. 10 ), but they are also consistent with a shift from HCO-and CL-secretion to that of CL-secretion alone (Figs. 10  and 1 1) . Second, Widdicombe (20) observed that when monolayers were bathed in solutions containing CL-and HCO-, the addition of acetazolamide did not attenuate the ISC response to cAMP. We also observed this lack of inhibition by acetazolamide alone. However, after inhibiting CL-secretion with bumetanide, the subsequent addition of acetazolamide inhibited I.C. These results are also consistent with the notion that the (25) . The alkalinization of airway fluid might be important to pulmonary defense mechanisms such as mucociliary clearance; for example, ciliary beat frequency is optimal at pH values of 7.0 to 9.0 (26, 27) . These results suggest the possibility that a defect in HCO-secretion by airway epithelia may contribute to the pathophysiology of CF pulmonary disease.
